Generation of human induced pluripotent stem cell lines from five patients with Myofibrillar myopathy carrying different heterozygous mutations in the DES gene.


Journal

Stem cell research
ISSN: 1876-7753
Titre abrégé: Stem Cell Res
Pays: England
ID NLM: 101316957

Informations de publication

Date de publication:
08 Feb 2024
Historique:
received: 15 01 2024
accepted: 04 02 2024
medline: 15 2 2024
pubmed: 15 2 2024
entrez: 14 2 2024
Statut: aheadofprint

Résumé

Myofibrillar myopathy (MFM) is a rare genetic disorder characterized by muscular dystrophy that is often associated with cardiac disease. This disease is caused by mutations in several genes, among them DES (encoding desmin) is the most frequently affected. Peripheral blood mononuclear cells from 5 different MFM patients with different DES mutations were reprogrammed into induced pluripotent stem cells (IPSC) using non-integrative vectors. For each patient, one IPSC clone was selected and demonstrated pluripotency hallmarks without genomic abnormalities. SNP profiles were identical to the cells of origin and all the clones have the capacity to differentiate into all three germ layers.

Identifiants

pubmed: 38354647
pii: S1873-5061(24)00036-9
doi: 10.1016/j.scr.2024.103338
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103338

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Pierre Joanne (P)

Sorbonne Université, Institut de Biologie Paris-Seine (IBPS), CNRS UMR 8256, Inserm ERL U1164, Biological Adaptation and Ageing, Paris, France. Electronic address: pierre.joanne@sorbonne-universite.fr.

Yeranuhi Hovhannisyan (Y)

Sorbonne Université, Institut de Biologie Paris-Seine (IBPS), CNRS UMR 8256, Inserm ERL U1164, Biological Adaptation and Ageing, Paris, France.

Alexandre Simon (A)

Sorbonne Université, Institut de Biologie Paris-Seine (IBPS), CNRS UMR 8256, Inserm ERL U1164, Biological Adaptation and Ageing, Paris, France.

Gaëlle Revet (G)

Sorbonne Université, Institut de Biologie Paris-Seine (IBPS), CNRS UMR 8256, Inserm ERL U1164, Biological Adaptation and Ageing, Paris, France.

Romain Diot (R)

Assistance Publique-Hôpitaux de Paris, Université Paris Saclay, Hôpital Antoine Béclère, Service d'Histologie, Embryologie et Cytogénétique, Clamart, France.

Gabriel Friob (G)

Sorbonne Université, Institut de Biologie Paris-Seine (IBPS), CNRS UMR 8256, Inserm ERL U1164, Biological Adaptation and Ageing, Paris, France.

Denisa Calin (D)

Sorbonne Université, Institut de Biologie Paris-Seine (IBPS), CNRS UMR 8256, Inserm ERL U1164, Biological Adaptation and Ageing, Paris, France.

Zhenlin Li (Z)

Sorbonne Université, Institut de Biologie Paris-Seine (IBPS), CNRS UMR 8256, Inserm ERL U1164, Biological Adaptation and Ageing, Paris, France.

Anthony Béhin (A)

Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Inserm UMR_S 974, Paris, France.

Karim Wahbi (K)

AP-HP, Cochin Hospital, Cardiology Department, Paris, France; Université de Paris, Paris, Paris Cardiovascular Research Center (PARCC), INSERM Unit 970, Paris, France.

Gérard Tachdjian (G)

Assistance Publique-Hôpitaux de Paris, Université Paris Saclay, Hôpital Antoine Béclère, Service d'Histologie, Embryologie et Cytogénétique, Clamart, France.

Onnik Agbulut (O)

Sorbonne Université, Institut de Biologie Paris-Seine (IBPS), CNRS UMR 8256, Inserm ERL U1164, Biological Adaptation and Ageing, Paris, France. Electronic address: onnik.agbulut@sorbonne-universite.fr.

Classifications MeSH